RCMI International Symposium on Health Disparities
November 12-15, 2000
San Juan, Puerto Rico

Scientific Presentations
Wednesday, November 15, 2000
Morning Session

Cancer

Invited Speakers

INTRODUCTION AND OVERVIEW
OF MINI-SYMPOSIUM
Lovel Jones, Ph.D.
M.D. Anderson Cancer Center

ROLE OF INTERLEUKIN II
IN BREAST CANCER METASTASES
Edna Mora, M.D.
University of Puerto Rico
School of Medicine

ALABAMA REACH 2000:
A COMMUNITY EMPOWERMENT PROGRAM
TO ELIMINATE BREAST AND CERVICAL CANCER
DISPARITY IN AFRICAN AMERICAN WOMEN
Mona Fouad, M.D., M.P.H.
University of Alabama
Birmingham Cancer Center

IMMUNOTHERAPY IN LEUKEMIAS AND LYMPHOMAS
Larry Herrera,M.D.
Scott and White Memorial Hospital

GENETIC TESTING FOR BRCA1/2 MUTATIONS
Chanita Hughes, Ph.D.
Georgetown University Medical Center

Oral Presentations
(click on titles for abstracts)

• Different apoptotic mechanisms are involved in the development of Adriamycin resistance by pleural and bone metastatic breast carcinoma (BRCa) cell
  Dr. Edna Mora

• Assessment of Spirituality as a Function of Quality of Life in Prostate Cancer patients
  Dr. Janice Bowie

• Mechanistic Studies of Caspase-3/RAD51 Interactions in Breast Cancer
  Dr. Erika T. Brown

• Breast Cancer in Hispanic Populations
  Dr. Edna Mora

• Effects on JAK 1 Expression and Cell Growth in BPV E5 and V0SIS Transformed Fibroblasts Treated with a PDGF-B Receptor Kinase Inhibitor
  Dr. Deena M. Keglor-Ebo

  Closing Remarks
  Dr. M. Alfred Haynes